Business Context and Reporting Period
This Form 8-K was filed by Core Scientific, Inc. on October 10, 2025. The filing serves as a Regulation FD disclosure regarding an Investor Presentation furnished in connection with an upcoming Special Meeting of stockholders scheduled for October 30, 2025. The primary purpose of the meeting is to consider and vote on a proposal to adopt the Agreement and Plan of Merger dated July 7, 2025, between Core Scientific, CoreWeave, Inc., and Miami Merger Sub I, Inc.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity figures for the current or prior periods. This document is a procedural filing related to a corporate transaction and does not contain a financial results summary.
Material Changes
The material change disclosed is the progression of the proposed merger transaction with CoreWeave, Inc. Key developments include:
- The registration statement on Form S-4 was declared effective on September 26, 2025.
- A definitive proxy statement was filed by Core Scientific on September 26, 2025.
- CoreWeave filed a prospectus on September 26, 2026 (as stated in the text).
- Representatives of Core Scientific are presenting an Investor Presentation to investors and analysts regarding the merger.
Guidance, Outlook, and Risks
Outlook and Management Commentary: Management is actively soliciting votes for the merger proposal at the Special Meeting. The filing emphasizes that the Investor Presentation is being furnished to facilitate investor understanding of the transaction.
Risks and Contingencies: The filing explicitly states that this communication is not a substitute for the registration statement, proxy statement, or prospectus. It urges investors to read these documents in their entirety before making any voting or investment decisions, as they contain important information about the proposed transaction. The filing also notes that no offer or solicitation of securities is being made in jurisdictions where such actions would be unlawful.
Investor Verification Checklist
- Verify the details of the Agreement and Plan of Merger dated July 7, 2025, in the effective Form S-4 registration statement.
- Review the definitive proxy statement filed on September 26, 2025, for voting instructions and transaction terms.
- Confirm the date and logistics of the Special Meeting scheduled for October 30, 2025.
- Examine the Investor Presentation (Exhibit 99.1) for specific financial projections or strategic rationale not detailed in this 8-K.
- Check for any amendments or supplements to the proxy statement or prospectus filed after September 26, 2025.